Ginkoum Capsules 80 mg, # 60

Ginkoum caps.

80mg No. 60

Name ENG

GINKGOUM

Clinical and pharmacological group

A drug that improves cerebral and peripheral circulation

ATX code

Ginkgo biloba

Dosage

80mg

Indications

Cerebral circulation disorders, accompanied by disorders of attention, memory impairment, decreased intellectual abilities, dizziness, tinnitus, headache

violations of peripheral blood circulation and microcirculation, accompanied by a feeling of coldness in the limbs, pain when walking, painful cramps and heaviness in the legs, paresthesias

dysfunction of the inner ear, manifested by dizziness, unsteady gait and tinnitus.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Hypersensitivity to drug components

decreased blood clotting

erosive gastritis

peptic ulcer of the stomach and duodenum in the acute stage

acute disorders of cerebral circulation

pregnancy

lactation period

children's age up to 12 years (due to the lack of sufficient clinical data).

INN / Active ingredient

Ginkgo biloba leaf extract

Specifications

Category

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Capsules

Manufacturer country

Russia

Package quantity, pcs

60

Scope of application

Neurology

,

Psychiatry

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Evalar

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal angioprotective agent

Anatomical and therapeutic characteristics

N06DX02 Ginkgo Biloba leaf extract

Dosage form

Capsules

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Inside with a small amount of liquid, regardless of the meal.

< br> If a different dosage regimen has not been recommended by the doctor, you should adhere to the following recommendations for taking the drug.

< br> For symptomatic treatment of disorders of cerebral circulation: 1-2 capsules (corresponds to 40-80 mg of standardized dry extract of ginkgo biloba) 3 times a day.

The duration of the course of treatment is at least 8 weeks.

< br> For peripheral circulatory disorders: 1 capsule (corresponds to 40 mg of standardized dry extract of ginkgo biloba) 3 times a day or 2 capsules (corresponds to 80 mg of standardized dry extract of ginkgo biloba) 2 times a day.

The duration of the course of treatment is at least 6 weeks.

< br> For vascular or involutional pathology of the inner ear: 1 capsule (corresponds to 40 mg of standardized dry extract of Ginkgo biloba) 3 times a day or 2 capsules (corresponds to 80 mg of standardized dry extract of Ginkgo biloba) 2 times a day.

< br> If the drug was missed or an insufficient amount was taken, the subsequent administration should be carried out as indicated in this manual, without any changes.

Dosage (volume) of the substance in the preparation

:

dry extract of leaves of Ginkgo biloba standardized with a content of flavone glycosides 22-27% and terpene lactones 5-12% 80 mg